Different Types of Diabetes

‌

Dr. C.C. King, Diabetes Research Connection

Sunday, 24 October 2021, 5pm PDT (12am GMT)

Join us:

Zoom:  https://us02web.zoom.us/j/81100950992

YouTube Livestream:  https://www.youtube.com/c/LOOPandLEARN

(This event will be recorded)

Charles (C.C.) King is Board Chair/ President and Research Scientist with the Diabetes Research Connection (San Diego, CA).

Dr. King may also talk about several of the funded projects underway at the Diabetes Research Connection, such as:

• Yi Wang: Will understanding the function of a specific gene in a protein reveal the cause of T1D? https://diabetesresearchconnection.org/.../gene-protein.../
• Yao Wang: Will understanding why normally good but aging beta cells accumulate with the progression of T1D unlock the mystery of this disease? You can view her project. https://diabetesresearchconnection.org/.../good-but.../
• Risa Wolf: Using Autonomous Artificial Intelligence (AI) to Improve Early Detection of Diabetic Retinopathy in Children with T1D You can view her project. https://diabetesresearchconnection.org/projects/wolf/
• Yen-shan Chen: Bionic Insulin Pump - a Tarson Family funded project. You can view his project. https://diabetesresearchconnection.org/.../bionic.../

Replay:  Gastric/Digestive Issues in T1D

‌

Dr. Marina Basina & Dr. Linda Nguyen
Stanford University

Though gastrointestinal (GI) complications are common among long-term T1Ds, changes in the gut begin as early as 6 months after diagnosis of T1D, even in young children. The awareness of these complications is low among physicians. Early identification and appropriate management of GI complications will improve both diabetic management and quality of life.

Replay:  Dr. Elliot Botvinick, UC Irvine

‌

Developer of iGLOBE

(Insulin+Lactate+Oxygen+ Beta-hydroxybutyrate LifeStrip)

iGLOBE is a first-of-its-kind device that will simultaneously measure insulin, glucose, lactate, oxygen, and the ketone body beta-hydroxybutyrate with a single probe inserted just beneath the skin.  It will include continuous insulin monitoring and improve dosing efficacy by providing real-time feedback on the dynamics of insulin pump therapy as well as real-time estimates of a patient’s sensitivity to the insulin.

Replay:  Dr. Nally, Pediatric Endocrinologist, Yale University School of Medicine

‌

Laura Nally, MD works at Yale University as an Assistant Professor and receives funding from the National Institutes of Health to study metabolic changes that occur on very low carbohydrate diets in youth with T1D.

Below, you will find links to ISPAD guidelines for PreSchool T1Ds, as well as Dr. Nally's paper on Looping in Pregnancy.